Voleon Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Voleon Capital Management's BMY Position: Q2 2026 in Review
Voleon Capital Management increased its Bristol-Myers Squibb (BMY) stake by 769% in Q2 2026, buying an estimated $3.26M and bringing the position to 64,106 shares worth $3.69M. The position accounts for 0.07% of the portfolio, ranked #264.
Voleon Capital Management first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Voleon Capital Management held 64,106 shares of Bristol-Myers Squibb worth $3.69M as of Q2 2026.
- Voleon Capital Management bought 56,726 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.26M.
- Bristol-Myers Squibb made up 0.07% of Voleon Capital Management's portfolio in Q2 2026, its #264 holding.
- Voleon Capital Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.